News

Rising Endometrial Cancer Rates Spur New Approaches to Prevention

An example of a nonendometrioid cancer. Posted June 28, 2022

Unlike many other cancers, the incidence and death rates for uterine cancer are rising.

Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for the same time frame.

Over 90% of uterine cancers begin in the endometrium, the tissue lining the uterus. There are two main subtypes of endometrial cancer, endometrioid and nonendometrioid, and the subtypes are showing different trends, a recent NCI-led study found.

All | 2022 | 2021 | 2020 | 2019

Women Experience More Side Effects from Pelvic Radiation than Realized

Women undergoing radiation therapy for cervical or uterine cancer have a much higher incidence of serious side effects than previously realized, according to results from a new clinical trial. This information may help women... Read More

POSTED: 04/08/2020
SOURCE: NCI Cancer Currents Blog

An older woman reading a tablet.

Experimental Drug Prevents Doxorubicin from Harming the Heart

The chemotherapy drug doxorubicin is used to treat many types of cancer, but some patients who receive the drug develop heart problems. Using new insights into how doxorubicin damages the heart, researchers have identified... Read More

POSTED: 04/06/2020
SOURCE: NCI Cancer Currents Blog

An illustration displaying the experimental drug BAI1 (yellow) which inhibits the BAX protein using a novel binding site (green) and prevents the death of heart cells.

Researchers Search the Genome for Clues to Early Age Onset Cancers in Racial/Ethnic Minorities

While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than... Read More

POSTED: 03/05/2020
SOURCE: Cancer Prevention Science Blog
Minority Underserved NCORP Sites Taking Part in the Early Onset Malignancy Initiative

Nutrition Frontiers - Winter 2020

RESEARCH UPDATE: ON THE CLINICAL FRONT Genetic Variants May Partially Explain Response to Tomato Juice Intake in Men with Prostate Cancer Tomato product and lycopene intakes are associated with reduced prostate cancer risk... Read More

POSTED: 02/19/2020
SOURCE: DCP News

Image of a man holding up a glass of tomato juice.

Optimizing Clinical Interventions for Prevention of Cervical Cancer and HPV-related Cancers in People Living with HIV

Cervical cancer is highly preventable, yet it is not fully prevented. Significant advancements in our understanding of the human papillomavirus (HPV)-linked development of cervical cancer have created highly effective... Read More

POSTED: 02/03/2020
SOURCE: Cancer Prevention Science Blog
Members of the US-Latin American-Caribbean Clinical Trials Network and National Cancer Institute staff.

Preventing the Progression of Low-Risk Localized Prostate Cancers: A New Frontier

In the path toward understanding the development and ultimate prevention of prostate cancer, researchers are studying how to keep low-grade, early stage prostate cancer being monitored on Active Surveillance from progressing... Read More

POSTED: 01/17/2020
SOURCE: Cancer Prevention Science Blog
Infographic: Percent of Prostate Cancer Cases by Stage

New Grantees Gather at Combined NCI Workshop

Division of Cancer Prevention New Grantees with Acting DCP Division Director Dr. Debbie Winn (first row center). In November 2019, the NCI Division of Cancer Prevention (DCP) for the first time held a New Grantee Workshop... Read More

POSTED: 01/14/2020
SOURCE: DCP News

Division of Cancer Prevention New Grantees with Acting DCP Division Director Dr. Debbie Winn.

Pages